CD79A and kidney disorder: Because recurrent and de novo IgAN are likely to have different clinical implications, the pathologic findings in cases where the patient’s native kidney disease is not known may be of some help in assessing whether the IgA deposits present are more likely to represent recurrent or de novo disease.